Diastolic compliance of the left ventricle in man

Am J Cardiol. 1975 Aug;36(2):193-201. doi: 10.1016/0002-9149(75)90525-1.

Abstract

Two coordinates of left ventricular end-diastolic pressure (P) and volume (V) were provided by the infusion of angiotensin in 22 patients. The slope (k) of the ln P-V relation, coupled with knowledge of the operating (end-diastolic) pressure allows determination of end-diastolic volume compliance (dV/VdP). Estimates of end-diastolic compliance from a single coordinate of pressure and volume compared well (r equals 0.90) with the two coordinate method, whereas for specific compliance (deltaV/V1 deltaP) appeared to be misleading in cases of idiopathic hypertrophic subaortic stenosis and congestive cardiomyopathy. Since volume compliance is determined in part by the operating pressure, compliance may be reduced in small, normal or enlarged ventricles. Left ventricular linear compliance was derived from volume compliance and was normalized for left ventricular wall thickness. The product of linear compliance and end-diastolic stress provides an index of myocardial strain, termed "muscle fiber stretch," which may be related to systolic performance and thus allow comparison of length-performance relations in ventricles with normal and abnormal compliance.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Angina Pectoris / physiopathology
  • Angiotensin II / pharmacology
  • Aortic Valve Stenosis / physiopathology
  • Blood Pressure / drug effects
  • Cardiac Catheterization
  • Cardiac Output
  • Cardiac Volume
  • Cardiomegaly / physiopathology
  • Cineangiography
  • Coronary Disease / physiopathology
  • Female
  • Heart / physiopathology
  • Heart Diseases / diagnostic imaging
  • Heart Diseases / physiopathology*
  • Heart Function Tests / methods*
  • Heart Rate / drug effects
  • Heart Ventricles / physiopathology*
  • Hemodynamics / drug effects
  • Humans
  • Male
  • Mathematics
  • Middle Aged
  • Myocardial Contraction / drug effects
  • Prognosis

Substances

  • Angiotensin II